Observational, prospective multicenter Life quality in relation to fatigue and hand-foot syndrome Patients With Metastatic Renal Carcinoma Treated with Tyrosine Kinase Inhibitor Frontlines (Troy Studio)
Phase of Trial: Phase IV
Latest Information Update: 28 Jul 2017
At a glance
- Drugs Pazopanib (Primary) ; Sorafenib (Primary) ; Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- Acronyms TROYA
- Sponsors Pfizer
- 27 Feb 2017 Status changed from not yet recruiting to recruiting.
- 14 Jan 2017 Status changed from recruiting to not yet recruiting.
- 22 Dec 2016 Status changed from not yet recruiting to recruiting.